Hotchkis & Wiley Capital Management
BSX icon

Hotchkis & Wiley Capital Management’s Boston Scientific BSX Stock Holding History

Hotchkis & Wiley Capital Management’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,941,600
Closed -$86M – 493
2022
Q1 		$86M Sell
1,941,600
-6,800
-0.3% -$295K 0.27% 74
2021
Q4 		$82.8M Sell
1,948,400
-7,600
-0.4% -$319K 0.26% 75
2021
Q3 		$84.9M Sell
1,956,000
-7,400
-0.4% -$327K 0.27% 75
2021
Q2 		$84M Sell
1,963,400
-22,900
-1% -$963K 0.26% 75
2021
Q1 		$76.8M Buy
+1,986,300
New +$75.2M 0.23% 73

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Hotchkis & Wiley Capital Management's BSX Position: Q2 2022 in Review

Hotchkis & Wiley Capital Management sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 1,941,600 shares — an estimated $86M sold.

Hotchkis & Wiley Capital Management first reported a position in BSX in Q1 2021 and held it in 5 quarters. The position peaked at $86M in Q1 2022. 878 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Hotchkis & Wiley Capital Management reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Hotchkis & Wiley Capital Management sold 1,941,600 Boston Scientific shares in Q2 2022, an estimated $86M.
  • Hotchkis & Wiley Capital Management first reported a position in Boston Scientific in Q1 2021 and held it in 5 quarters.
  • Hotchkis & Wiley Capital Management's Boston Scientific position peaked at $86M in Q1 2022.
  • 878 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Hotchkis & Wiley Capital Management's 13F filing for Q2 2022, filed 12 Aug 2022.